inTest Raises Q2 Prelim Sales Guidance from $32.000M-$34.000M to $35.000M vs $33.013M Est
inTest (AMEX:INTT) raises Q2 Prelim sales outlook from $32.000 million-$34.000 million to $35.000 million vs $33.013 million estimate.
inTest said its second-quarter sales will be higher than it thought before—about $35 million instead of $32–$34 million. This is a sign the company is doing better than people expected, which usually makes investors feel more hopeful about the business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.